Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, and Rodgers GM (1993)
Schalkwijk, C
The MASLD trial data showed dramatic liver fat reduction even at moderate doses, though maximum liver fat clearance was observed at 12 mg
One of the primary palliative treatment options for advanced hepatocellular carcinoma is transcatheter arterial chemoembolization (TACE)
Key Takeaways GLP-1 support supplements target the predictable consequences of drug-driven appetite suppression: lean-mass loss, sub-DRI protein, fiber, and micronutrient intake, and GI side effects
And our current thinking about obesity, and one of the components of the disease of obesity, is that some individuals although they all have GLP-1 and these other gut hormones, amylin, glucagon, GIP, that's what they're called that signal, for some reason, is not getting to the brain in ample amounts to tell the individual to feel full, satiated, and stop eating